Technology

Telemedicine: The Long-Term Solution to Physician Shortages and Specialty Coverage

 
 
Jason Povio, the President and COO for Eagle Telemedicine, the leader in technology-enabled, inpatient care for sustainable healthcare resilience again joins eHealth Radio and the Healthcare and Telemedicine Channels.
Listen to interview with host Eric Michaels and guest Jason Povio discuss the following:
Many of today’s hospitals, rural hospitals in particular, face a number of challenges, in delivering specialty coverage. What are some of most significant short-term and long-term obstacles that rural hospitals face?
How is Telemedicine solving the challenges faced by these hospitals?
What are some ways telemedicine is delivering long-term value?
What approach does your company, Eagle Telemedicine take to address inpatient and outpatient care for hospitals? What are some key differentiators that you provide?
Is it working? Are these hospitals seeing improvements as a result of implementing telemedicine?
Jason Povio serves as President and Chief Operating Officer for Eagle Telemedicine. In this role, Jason has oversight over all aspects of the business, including operations, program implementation, post-implementation support, credentialing as well as marketing and business development.
He has a diverse background in systems engineering along with broad experience in healthcare, working in large integrated healthcare systems in a number of operational excellence and executive positions.
Jason received his Bachelor of Science in Industrial Engineering and Masters of Science in Engineering Management from the University of South Florida along with several Graduate Certificates in Quality and Change Management. He also holds a Lean Healthcare Certification and is a Lean Six Sigma Black Belt from the University of Michigan.
Website: https://www.eagletelemedicine.com 
Social Media Links: Facebook: https://facebook.com/EagleTelemedicine  Twitter: @EagleTelemed Linkedin: https://linkedin.com/company/eagle-telemedicine 
People also listened to this: Transform an Uncontrolled Mind into a Creative Mind in 4 Simple Steps

Interview with Alex Kleinman, Senior Vice President, Global Segment Leader of Healthcare at Genpact

 
 
Alex Kleinman, the Senior Vice President & Global Segment Leader, of Healthcare at Genpact that leads the Healthcare business for Genpact and serves as Strategy Leader for the company's Consumer & Healthcare vertical joins eHealth Radio and the Healthcare and Technology Channels.
Listen to interview with host Eric Michaels and guest Alex Kleinman discuss the following:
Can you tell us about Genpact and your role within the company?
The future of healthcare is data-driven, but can you explain how analytics is powered by artificial intelligence (AI) and machine learning (ML)?
Can you share some AI use cases for our listeners to really understand the benefits to patients and the role of Genpact in the overall process?
How do you see AI within the healthcare industry evolving?
What do you see for the future of Genpact in the healthcare vertical?
Alex Kleinman leads the Healthcare business for Genpact and serves as Strategy Leader for the company’s Consumer & Healthcare vertical. He led Genpact’s Pharmacovigilance Signal Management SaaS business until its sale in 2022.
He’s known as a creative strategic thinker and problem solver that builds and mobilizes talented, diverse teams to drive transformation for clients. Alex previously served as Strategy & Growth Leader and Senior Client Partner for Genpact’s Consumer Goods, Retail, Life Sciences & Healthcare (CGRLH) business.
Alex joined Genpact in 2018 from Gartner, where he was Head of Corporate Strategy and Partnerships for its CEB subsidiary. His 20-year career includes stints within the Healthcare and Life Sciences practices of McKinsey & Company, the Advisory Board Company, and molecular imaging start-up Bioscan. His responsibilities within these firms included corporate development, marketing and general management responsibilities.
Alex holds a BA from Haverford College and an MBA from the University of Pennsylvania’s Wharton School. He is based in the Washington, DC area.
Website: https://www.genpact.com
Social Media Links: Facebook: https://www.facebook.com/ProudToBeGenpact  Linkedin: https://www.linkedin.com/company/genpact  Twitter: https://twitter.com/genpact 
People also listened to this: Discovering emotional scars that can run our lives

How Artificial Intelligence is Transforming Healthcare for the Better

 
 
David Sides, CEO and President of NextGen Healthcare, a leading provider of innovative healthcare technology and data solutions joins eHealth Radio and the Healthcare & Technology Channels.
Listen to interview with host Eric Michaels and guest David Sides discuss the following:
Can you give an overview of how AI is already being used in healthcare?
Responsible AI use is of critical importance—especially in healthcare. How does NextGen ensure that AI technologies are deployed ethically and responsibly?
AI can naturally raise concerns about job displacement. How do you view the relationship between AI and healthcare workers?
How do you see the role of AI in healthcare evolving over the next 5 years?
What is at risk if the healthcare industry fails to embrace AI? 
David Sides was appointed as Chief Executive Officer and President for NextGen Healthcare, effective September 22, 2021. He brings a breadth of global commercial and operations experience leading premier healthcare technology companies to the role.
He most recently served as Chief Operating Officer at Teladoc Health, the global leader in virtual care, where he led the Company’s worldwide commercial and operations teams. During his tenure, Teladoc’s revenues doubled in 2020 and are currently on track to exceed $2 billion in 2021. Previously, he served as CEO of Streamline Health, which offers revenue cycle management solutions for healthcare providers. David led the full-scale turnaround of Streamline Health, growing revenue, EBITDA and cash flow organically. Prior to that, he was recruited by TPG to serve as CEO of iMDsoft, an Israeli headquartered provider of clinical information systems and electronic medical records for critical, perioperative and acute care organizations. Under David’s leadership, iMDsoft delivered a more than 30% increase in revenue while investing in new systems and processes.
Earlier in his career, David worked for Cerner Corporation, a leading supplier of health information technology services, devices and hardware, from 1995-2012. Among other roles, he served as Senior Vice President, World Wide Consulting, where he led Cerner’s professional services in 24 countries and owned global P&L and functional responsibilities from sales through implementation for the business. At Cerner, he created new methodologies for deployment, new service lines and development plans for 3,500 associates, growing the consulting business from $643 million in 2008 to $1.031 billion in 2012.
David is a former director at EMIS Group, a major provider of healthcare software, information technology and related services in the UK, and at Streamline Health. He is a Fellow in the American College of Healthcare Executives.
David holds a bachelor’s degree in biophysics from the University of California, Berkeley, and an MBA and MHA from the University of Missouri, Columbia.
Website: https://www.nextgen.com 
Social Media Links: Facebook: https://www.facebook.com/NextGenHealthcare  Instagram: https://www.instagram.com/nextgenhealthcare  Linkedin: https://www.linkedin.com/company/nextgen-healthcare-information-systems  Twitter: https://twitter.com/NextGen 
People also listened to this: Meet the company that’s helping people shift mindsets for profoundly better living

AI-powered technology enabling early detection of serious health diseases

 
 
Jim Kean, the CEO of Molecular You joins eHealth Radio and the Health News and Technology Channels to discuss how their AI-powered technology is enabling early detection of serious health diseases even before symptoms appear.
Listen to interview with host Eric Michaels and guest Jim Kean discuss the following:
What particular problems does Molecular You’s solution solve?
What inspired you to feel passionate about this cause?
How important is AI to what you do?
How do you think this will change the healthcare world?
What would you recommend to listeners who want to be more proactive about their long-term health today?
Jim Kean is the CEO of Molecular You. He is a senior technology executive with an innovative career focused on making healthcare easier by pioneering disruptive consumer-oriented health and wellness digital experiences. The consistent theme: creating user delight, loyalty, and retention while fundamentally re-engineering the cost of delivery.
As the former CEO of WellnessFx™, he provided affordable consumer health services, earning recognition as the 2012 Innovative Company of the Year. Kean also spearheaded online health communities as President of Sapient Health Network, which merged with WebMD in 1999. After WebMD, Jim served as Entrepreneur in Residence with Alloy Ventures of Palo Alto. With a rich history of scaling companies, he continues to lead groundbreaking ventures, most recently as CEO of Molecular You.
 
Website: https://www.molecularyou.com
People also listened to this: Making It Through Your First Holiday Season After a Divorce

A Breakthrough Solution for Treating Central Nervous System Disorders Including Strokes and Cluster Headaches

 
Dr. Peter Bonutti, M.D., a surgeon, inventor, author, professor, consultant, and entrepreneur with over 30 years of experience joins eHealth Radio and the Health News and Technology Channels.
Listen to interview with host Eric Michaels and guest Dr. Peter Bonutti discuss the following:
Bonnutti Technologies has a track record of identifying problems and has more than 500 patents—tell me about your latest breakthrough with Releave which is being used by 700 patients already.
What is the problem you are solving?
How many people suffer from cluster headaches and neuro disorders?
What is the science behind Releave? How does Releave work? Is it an implant and a device?
There is a lot of talk about chip implants…not approved by the FDA. You are approved and have patients, how hard was the process?
How are you funded and who is the team behind the project?
How can potential patients and medical professionals learn more about Realeve?
Dr. Peter Bonutti, M.D. is a surgeon, inventor, author, professor, consultant, and entrepreneur with over 30 years of experience. He is the founder of Bonutti Research, a medical device incubator that has developed products and technology used around the world, including UVCeed, and maintains his clinical and surgical practice, focusing on adult knee and hip arthroplasty and integration of robotics into surgical procedures.
Dr. Bonutti is a pioneer in Minimally Invasive Surgery, has over 500 patents and applications, more than 700 licenses and multiple FDA-approved products to date. Major corporations leveraging his technology include Hitachi, Medtronic, Kyphon, Covidien, US Surgical, Biomet, Arthrocare, Synthes, Zimmer/Biomet and Stryker. He is a prolific speaker, lecturing internationally, and has trained over 100 surgeons on his surgical techniques.
In his career, Dr. Bonutti has received more than a dozen industry honors and awards for his achievements. Dr. Bonutti earned his medical degree at University of Cincinnati College of Medicine and completed his Orthopaedic Surgery Residency at Cleveland Clinic Foundation with international fellowships in Canada, Australia, and Austria.
Website: https://www.realeve.net
People also listened to this: The Psychology of Asking for Forgiveness and Forgiving

A need in the US marketplace for international medical offerings

 
John Mooney President and Co-Founder, International Medical Lasers, a medical industry leader in sourcing the world's highest quality surgical devices for the U.S. medical marketplace & Paolo Salvadeo, CEO, DEKA M.E.L.A., that has more than three decades of international medical laser experience joins eHealth Radio and the Health News and Technology Channels.
Listen to interview with host Eric Michaels and guests John Mooney & Paolo Salvadeo discuss the following:
Mr. Salvadeo:  This is interesting to see the DEKA Italian laser product here in the U.S.  Can you tell us what market need the laser solves for U.S. patients?


Mr. Mooney:  Your company, International Medical Laser, specializes in global medical technology.  Can you tell us about your company saw a need in the US marketplace for international medical offerings?


Mr. Salvadeo:   I saw in your LinkedIn profile that you have been honored as a Knight of the Order of Merit of the Italian Republic - Master of Work.  Can you explain how someone earns such a prestigious honor ?
Mr. Mooney:  you are in a unique position to evaluate U.S. versus global medical technology offerings.  Can you share some differences - or similarities - between domestic and international medical equipment - either in the design, how patient need is met or other criteria?
Mr. Salvadeo:  Can you share some of your humanitarian work with us?  We understand you undertook an initiative that engaged the Pope?

IML sources state-of-the-art medical devices from around the globe, and makes them available in the U.S. We work with top tier international manufacturers to provide innovative yet practical medical technology solutions for hospitals, surgical centers, and other institutions. Through its strong network of dealers, IML supports medical teams as they address patient care in hospitals, surgery centers and clinics across the U.S.
IML Links: Website: https://imlasers.com  LinkedIn: https://linkedin.com/company/international-medical-lasers  Facebook: https://facebook.com/IMLasersUS Twitter: https://twitter.com/IMLasers
DEKA Links: Website: https://dekalaser.com/usa Facebook: https://facebook.com/DEKALaser.Official Instagram: https://instagram.com/dekalaser_official LinkedIn: https://linkedin.com/company/deka-laser Youtube: https://youtube.com/user/DEKALASERTV 

Biotechnology company developing therapeutic candidates targeting drug-resistant and devastating cancers using ferroptosis

 
 
Randy Milby, the Chief Executive Officer and Chairman of Hillstream BioPharma, a biotechnology company developing therapeutic candidates targeting drug-resistant and devastating cancers using ferroptosis, an emerging new anti-cancer mechanism resulting in iron mediated cell death, and immuno-oncology targeted novel biologics joins eHealth Radio and the Cancer Information & Health News Channels.
Listen to interview with host Eric Michaels and guest Randy Milby discuss the following:
Please tell us a bit about your background and Hillstream BioPharma.
What developments are currently in Hillstream’s pipeline?
How does ferroptosis-targeted therapy differentiate from other cancer treatments currently available or under development?
Why is it important to Hillstream to develop drug resistant therapeutics for cancers with few treatment options?
What advice can you share with industry peers, key opinion leaders, or anyone pursuing R&D in the biotechnology space?
Looking ahead, what exciting advances do you think are on the horizon for Hillstream?
Mr. Milby previously served as Chief Executive Officer and Member of the Board of Directors at CorMedix, a publicly traded biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of inflammatory and infectious diseases. He is a seasoned executive who led the increase in market capitalization from $3M to a peak of $350M of Cormedix while improving the company’s financial position with capital raises from equity markets. He oversaw efforts to gain CE Market approval of Neutrolin® in the European Union and held increasing roles of responsibility at Goldman Sachs and Dupont Merck prior in his career.
 
Website: https://hillstreambio.com 
Social Media Links: Facebook: https://facebook.com/HillstreamBioPharma  Linkedin: https://linkedin.com/company/hillstream-biopharma  Twitter: https://twitter.com/HillstreamB 
People also listened to this: Checkable Medical: Revolutionizing Home Healthcare and Telemedicine

Why time is of the essence for innovation to improve mental health outcomes

 
 
John Letter the CEO of Proem Behavioral Health, formerly nView Health, the developer of the evidence-based clinical workflow software engine that helps providers triage patients and produce better mental health outcomes joins eHealth Radio and the Health News and Mental Health Channels.
Listen to interview with host Eric Michaels and guest John Letter discuss the following:
Could you share with me what Proem Behavioral Health does - how does your solution, work and overall industry impact reach researchers, healthcare providers and behavioral health and addiction specialists?
As we all know and hear frequently on the news, mental health is a critical area needing innovation due to the epidemic proportions of mental health issues and conditions. Why do you think taking not only new tech approaches to address this epidemic are needed, but also a reframe on mental health itself as being easily treated by providers? 
Beyond the stigma that can exist or lack of awareness among patients as well as some medical providers not being equipped till now to address mental health challenges, what do you think is needed that is tied to technology to help more people get the treatment they need?
As someone who is in a business leadership position within the healthcare industry more broadly, what do you recommend to healthcare innovations who may be entrepreneurs, or even innovation minded teams working within larger companies to make an impact that’s meaningful?
What are some areas of focus your team at Proem is focused on for the rest of this year that you hope will have made a positive change in the field by 2024?
John Letter is CEO of Proem Behavioral Health, formerly nView Health, developer of the evidence-based clinical workflow software engine that helps providers triage patients and produce better mental health outcomes. He is an experienced healthcare executive serving most recently as the President and COO of a successful population health company in the sleep health space.
John works tirelessly to help teams achieve sustainable growth while over-delivering on customer promises each day. At Proem, John is responsible for overall strategic direction, working alongside an incredible team focused on building digital health tools to help providers get the right answers, diagnoses and outcomes for their patients the first time. John and his wife reside in Atlanta and have two grown children.
Website: https://www.proemhealth.com
People also listened to this: How divorce and separation can drive someone to harm and even death

How To Peer Into The Future Using Technology For Seniors

 
 
Ryan McEniff, owner of WellAware Care, a fall detection and remote monitoring service for seniors living at home or in senior communities like assisted or independent living communities joins eHealth and the Senior Care and Technology Channels.
Listen to interview with host Eric Michaels and guest Ryan McEniff discuss the following:
What is WellAware Care service?
How did you get involved in this company?
How is it different from other fall detection companies like PERs?
Why is this important for seniors to have?
What is your data showing you with falls?
Ryan McEniff is the owner of Minute Women Home Care, a private home care company as well as WellAware Care. He is active in his community with the National Aging In Place Council as well as the host of his own podcast, The Caregiver's Toolbox.
Website: https://wellawarecare.com
Social Media Links: Facebook: https://facebook.com/wellawarecareLinkedin: https://linkedin.com/company/wellaware-care

The Role of FibroScan® in the Multi-Modal Management of Patients with Chronic Liver Disease

 
 
Dr. Tejas Joshi, Director of Liver Diseases and Assistant Professor at Marshall University School of Medicine in Huntington, WV joins eHealth Radio and the Liver Health and Health News Channels.
Listen to interview with host Eric Michaels and guest Dr. Tejas Joshi discuss the following:
Could you give an overview of what FibroScan is, and discuss why you decided to implement this into your practice?
How do you feel that the use of FibroScan has benefitted your practice and your unique patient population?
We’ve covered considerable benefits of this tool for patients. What is the value of FibroScan to the provider?
Which different practitioners could be involved in the liver management algorithm?
What advice would you give to those practitioners interested in implementing FibroScan into their practice?
Dr. Tejas Joshi is a New Jersey native who completed Hepatology and Liver transplantation training at Baylor University in Houston Texas prior to settling in Huntington, WV. He is now practicing Hepatology in West Virginia caring for unique patients in Appalachia with chronic liver diseases. He is also board certified in obesity medicine and utilizes that to care for his patients with metabolic syndrome associated liver disease. His clinical research interests include liver cancer, cirrhosis, fatty liver disease, obesity medicine, autoimmune liver disease, viral hepatitis and liver transplant outcomes.
Website: https://echosens.com
Social Media Links: Facebook: facebook.com/fibroscan.echosens  Linkedin: linkedin.com/company/echosens  Youtube: youtube.com/user/EchosensTV Twitter: twitter.com/Echosens